These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


411 related items for PubMed ID: 8777471

  • 1. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
    Ruilope LM, Simpson RL, Toh J, Arcuri KE, Goldberg AI, Sweet CS.
    Blood Press; 1996 Jan; 5(1):32-40. PubMed ID: 8777471
    [Abstract] [Full Text] [Related]

  • 2. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
    Oparil S, Barr E, Elkins M, Liss C, Vrecenak A, Edelman J.
    Clin Ther; 1996 Jan; 18(4):608-25. PubMed ID: 8879890
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension.
    Townsend R, Haggert B, Liss C, Edelman JM.
    Clin Ther; 1995 Jan; 17(5):911-23. PubMed ID: 8595643
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy.
    Rhee MY, Baek SH, Kim W, Park CG, Park SW, Oh BH, Kim SH, Kim JJ, Shin JH, Yoo BS, Rim SJ, Ha JW, Doh JH, Ahn Y, Chae JK, Park JB, Kim SK, Kim CH.
    Drug Des Devel Ther; 2015 Jan; 9():2847-54. PubMed ID: 26082615
    [Abstract] [Full Text] [Related]

  • 5. Losartan potassium as initial therapy in patients with severe hypertension.
    Dunlay MC, Fitzpatrick V, Chrysant S, Francischetti EA, Goldberg AI, Sweet CS.
    J Hum Hypertens; 1995 Nov; 9(11):861-7. PubMed ID: 8583463
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
    Weir MR, Elkins M, Liss C, Vrecenak AJ, Barr E, Edelman JM.
    Clin Ther; 1996 Nov; 18(3):411-28. PubMed ID: 8829017
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension.
    Gradman AH, Brady WE, Gazdick LP, Lyle P, Zeldin RK.
    Clin Ther; 2002 Jul; 24(7):1049-61. PubMed ID: 12182251
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of losartan on a background of hydrochlorothiazide in patients with hypertension.
    Soffer BA, Wright JT, Pratt JH, Wiens B, Goldberg AI, Sweet CS.
    Hypertension; 1995 Jul; 26(1):112-7. PubMed ID: 7607713
    [Abstract] [Full Text] [Related]

  • 15. Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension.
    Flack JM, Saunders E, Gradman A, Kraus WE, Lester FM, Pratt JH, Alderman M, Green S, Vargas R, Espenshade M, Ceesay P, Alexander J, Goldberg A, Study Group for Losartan in African Americans with Hypertension.
    Clin Ther; 2001 Aug; 23(8):1193-208. PubMed ID: 11558858
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.
    Fogari R, Taddei S, Holm-Bentzen M, Baszak J, Melani L, Schumacher K.
    Clin Drug Investig; 2010 Aug; 30(9):581-97. PubMed ID: 20593911
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy.
    Suh SY, Ahn T, Bae JH, Lim DS, Lee SU, Kim YK, Hyon MS, Kim WH, Han KR, Park HK.
    Clin Ther; 2014 Oct 01; 36(10):1402-11. PubMed ID: 25146365
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.